Exploring the Potential of Mesenchymal Stem Cell-Based Therapy in Mouse Models of Vascular Cognitive Impairment
Open Access
- 1 August 2020
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 21 (15) , 5524
Abstract
Closely linked to Alzheimer’s disease (AD), the pathological spectrum of vascular cognitive impairment (VCI) is known to be wide and complex. Considering that multiple instead of a single targeting approach is considered a treatment option for such complicated diseases, the multifaceted aspects of mesenchymal stem cells (MSCs) make them a suitable candidate to tackle the heterogeneity of VCI. MSCs were delivered via the intracerebroventricular (ICV) route in mice that were subjected to VCI by carotid artery stenosis. VCI was induced in C57BL6/J mice wild type (C57VCI) mice by applying a combination of ameroid constrictors and microcoils, while ameroid constrictors alone were bilaterally applied to 5xFAD (transgenic AD mouse model) mice (5xVCI). Compared to the controls (minimal essential medium (MEM)-injected C57VCI mice), changes in spatial working memory were not noted in the MSC-injected C57VCI mice, and unexpectedly, the mortality rate was higher. In contrast, compared to the MEM-injected 5xVCI mice, mortality was not observed, and the spatial working memory was also improved in MSC-injected 5xVCI mice. Disease progression of the VCI-induced mice seems to be affected by the method of carotid artery stenosis and due to this heterogeneity, various factors must be considered to maximize the therapeutic benefits exerted by MSCs. Factors, such as the optimal MSC injection time point, cell concentration, sacrifice time point, and immunogenicity of the transplanted cells, must all be adequately addressed so that MSCs can be appropriately and effectively used as a treatment option for VCI.Keywords
Funding Information
- National Research Foundation of Korea (NRF-2017R1D1A1B03033979)
- Korea Health Industry Development Institute (HI14C3484, HI18C0560)
This publication has 60 references indexed in Scilit:
- Availability of a Microglia and Macrophage Marker, Iba-1, for Differential Diagnosis of Spontaneous Malignant Reticuloses from Astrocytomas in RatsJournal of Toxicologic Pathology, 2013
- Soluble intracellular adhesion molecule-1 secreted by human umbilical cord blood-derived mesenchymal stem cell reduces amyloid-β plaquesCell Death & Differentiation, 2011
- Identification of pure subcortical vascular dementia using 11 C-Pittsburgh compound BNeurology, 2011
- Experimental models of vascular dementia and vascular cognitive impairment: a systematic reviewJournal of Neurochemistry, 2010
- Contribution of vascular pathology to the clinical expression of dementiaNeurobiology of Aging, 2010
- Foamy macrophages and the progression of the human tuberculosis granulomaNature Immunology, 2009
- Small Vessel Disease and Subcortical Vascular DementiaJournal of Clinical Neurology, 2006
- Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statementCytotherapy, 2006
- Choto-san, a Kampo formula, improves chronic cerebral hypoperfusion-induced spatial learning deficit via stimulation of muscarinic M1 receptorPharmacology Biochemistry and Behavior, 2005
- Correlates of hippocampal neuron number in Alzheimer's disease and ischemic vascular dementiaAnnals of Neurology, 2005